DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Anthrax vaccine, antitoxin and immunoglobulin, and CBRN medical countermeasure research, acquisition, legislation, funding, appropriations and oversight.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | Principal |
Homeland Security HOM
Anthrax vaccine, anthrax antitoxin, anthrax immune globulin and CBRN Medical Countermeasures research, acquisition and funding, legislation, appropriations, and oversight and medical countermeasure first responder preparedness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | Principal |
Medical/Disease Research/Clinical Labs MED
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | Principal |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.